Rahul Sharma

Interventional cardiologist / Cardiologist
Stanford Health Care - Palo Alto, United States of America

Latest contributions

Early treatment of severe aortic stenosis: do we need to wait?

20 May 2025 – From EuroPCR 2025

Rahul Sharma and Darren Walters share their perspectives on shifting treatment strategies for aortic stenosis (AS), with a focus on early intervention.

Their conversation draws on the EARLY TAVR trial, which compared transcatheter aortic valve replacement (TAVR) to clinical surveillance in patients with severe, asymptomatic AS at low surgical...

Early treatment of severe aortic stenosis: do we need to wait?

TAVI in bicuspid aortic valve disease

22 May 2025 – From EuroPCR 2025

Explore the unique challenges of TAVI in bicuspid aortic valve disease with a focus on long-term outcomes, residual gradients, prosthesis-patient mismatch, and anatomical subtype comparisons. This session draws on international registry data to inform clinical decision-making and optimize procedural strategies in this complex patient population.

TAVI in bicuspid aortic valve disease

Tricuspid hotline: new devices

22 May 2025 – From EuroPCR 2025

Discover cutting-edge developments in transcatheter tricuspid valve replacement with new device technologies. Review first-in-human trials, early outcomes from multicenter studies, and innovative designs that promise to advance tricuspid regurgitation treatment.

Tricuspid hotline: new devices

TAVI - Procedural complications

20 May 2025 – From EuroPCR 2025

Review procedural complications encountered during TAVI, including rare adverse events, management of balloon rupture, annulus rupture with tamponade, and unexpected intraoperative challenges. Gain insights into innovative rescue techniques and decision-making under critical conditions.

TAVI - Procedural complications

Transcatheter tricuspid valve replacement - LIVE case

15 May 2024 – From EuroPCR 2024

An 82-year-old male with a history of STEMI in 2013, stroke in 2018, cancer, and permanent AF, presented with acute heart failure with predominant right-side failure. Severe tricuspid regurgitation was identified.
The operators implanted an Evoque valve percutaneously under TEE guidance and general anaesthesia via the venous...

Transcatheter tricuspid valve replacement

How to best image the atrioventricular valves?

14 May 2024 – From EuroPCR 2024

This session, in collaboration with the PCR Tricuspid Focus Group, aims to provide a comprehensive understanding of how to image the atrioventricular valves (mitral and tricuspid) to assess their anatomy and pathology. It covers the step-by-step evaluation of the mitral and tricuspid valves using transesophageal echocardiography...

How to best image the atrioventricular valves?

Elevating quality of heart valve treatment through innovation: SAPIEN 3 Ultra RESILIA and EVOQUE valve systems

14 May 2024 – From EuroPCR 2024

Watch this session to explore how the SAPIEN 3 Ultra RESILIA valve can enhance lifetime management for patients, to find out more about the new treatment options available with the EVOQUE valve, identifying the patient populations that stand to benefit the most, and, additionally, to get...

Elevating quality of heart valve treatment through innovation: SAPIEN 3 Ultra RESILIA and EVOQUE valve systems

Latest developments in interventional valve therapies

06 Dec 2023 – From GulfPCR-GIM 2023

In this GulfPCR-GIM 2023 session, learn more about RESILIA, the calcium-blocking tissue found in Edwards' newest innovative system: the Sapien 3 Ultra Resilia. Then, move on from TAVI to the first mitral transcatheter edge-to-edge repair (TEER) performed in the Middle East using the PASCAL Precision System.

Latest developments in interventional valve therapies